Standout Papers

A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis 2012 2026 2016 2021 829
  1. A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis (2012)
    Brett Ley, Christopher J. Ryerson et al. Annals of Internal Medicine
  2. Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper (2017)
    David A. Lynch, Nicola Sverzellati et al. The Lancet Respiratory Medicine
  3. Idiopathic pulmonary fibrosis: Disease mechanisms and drug development (2020)
    Paolo Spagnolo, Jonathan A. Kropski et al. Pharmacology & Therapeutics
  4. Predicting Survival Across Chronic Interstitial Lung Disease (2013)
    Christopher J. Ryerson, Eric Vittinghoff et al. CHEST Journal
  5. Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis (2023)
    Carmen Wong, Kerri A. Johannson et al. European Respiratory Review

Immediate Impact

1 by Nobel laureates 8 from Science/Nature 65 standout
Sub-graph 1 of 21

Citing Papers

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis
2025 Standout
From geroscience to precision geromedicine: Understanding and managing aging
2025 Standout
7 intermediate papers

Works of Christopher J. Ryerson being referenced

Hypersensitivity pneumonitis
2020
Progression of fibrosing interstitial lung disease
2020
and 5 more

Author Peers

Author Last Decade Papers Cites
Christopher J. Ryerson 6758 2394 994 189 8.0k
Kirk D. Jones 5855 1909 737 133 8.6k
Kevin R. Flaherty 8703 2852 1096 168 10.4k
Gary M. Hunninghake 3649 1794 510 97 6.0k
David J. Lederer 8960 2765 674 200 12.4k
Steven D. Nathan 11639 3336 594 277 13.7k
Michael Walsh 4389 1391 500 154 10.7k
Charlie Strange 5985 1660 799 227 9.0k
Marlies Wijsenbeek 4171 1736 490 168 4.9k
Toby M. Maher 11842 3586 3192 321 14.5k
Daniel A. Culver 3980 3994 140 161 5.7k

All Works

Loading papers...

Rankless by CCL
2026